Icosabutate Exerts Beneficial Effects Upon Insulin Sensitivity, Hepatic Inflammation, Lipotoxicity, and Fibrosis in Mice
Icosabutate is a structurally engineered eicosapentaenoic acid derivative under development for nonalcoholic steatohepatitis (NASH). In this study, we investigated the absorption and distribution properties of icosabutate in relation to liver targeting and used rodents to evaluate the effects of ico...
Main Authors: | Anita M. van denHoek, Elsbet J. Pieterman, José W. van derHoorn, Marta Iruarrizaga‐Lejarreta, Cristina Alonso, Lars Verschuren, Tore Skjæret, Hans M.G. Princen, David A. Fraser |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-02-01
|
Series: | Hepatology Communications |
Online Access: | https://doi.org/10.1002/hep4.1453 |
Similar Items
-
Comment on “Hypercholesterolemia with consumption of PFOA-laced Western diets is dependent on strain and sex of mice” by Rebholz S.L. et al. Toxicol. Rep. 2016 (3) 46–54
by: Hans M.G. Princen, et al.
Published: (2016-01-01) -
Beneficial effects of elafibranor on NASH in E3L.CETP mice and differences between mice and men
by: Anita M. van den Hoek, et al.
Published: (2021-03-01) -
Beneficial Effects Exerted by Paeonol in the Management of Atherosclerosis
by: Li Lu, et al.
Published: (2018-01-01) -
Lipotoxicity in diabetic cardiomyopathy
by: Haffar, Taha
Published: (2019) -
Oxidative stress and lipotoxicity
by: Amy K. Hauck, et al.
Published: (2016-11-01)